Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
MoonLake Immunotherapeutics ( (MLTX) ) just unveiled an announcement.
MoonLake Immunotherapeutics announced the resignation of Dr. Kara Lassen from its board of directors due to her increased responsibilities at Roche Pharma Research & Early Development. Her departure, effective December 31, 2024, will reduce the board size from seven to six members. Additionally, the board has approved a long-term incentive program, including significant equity grants for key executives to vest over four years, enhancing executive retention and alignment with company goals.
More about MoonLake Immunotherapeutics
YTD Price Performance: -6.77%
Average Trading Volume: 283,751
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.6B
Find detailed analytics on MLTX stock on TipRanks’ Stock Analysis page.
